Similar Articles
441 Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
442 Emerging curative-intent minimally-invasive therapies for hepatocellular carcinoma
443 Loco-regional treatment of hepatocellular carcinoma: Role of contrast-enhanced ultrasonography
444 Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
445 Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study
446 Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics
447 Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration
448 Is there a role for liver transplantation in the treatment of hepatocellular carcinoma in non-cirrhotic liver?
449 Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma
450 Contrast-enhanced ultrasound manifestations of synchronous combined hepatocellular-cholangiocarcinoma and hepatocellular carcinoma: A case report
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA